Evidence map›Paper›PMID 37985979›Full record

ArticleBMC public health2023

Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the Tasmanian Eliminate Hepatitis C Australia Outreach Project, 2020-2022.

Joshua Dawe, Megan Hughes, Shannon Christensen, Louisa Walsh, Jacqueline A Richmond, Alisa Pedrana, Anna L Wilkinson, Louise Owen, Joseph S Doyle, EC Australia Partnership

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Joshua Dawe *Disease Elimination, Burnet Institute, Melbourne, Australia. joshua.dawe@burnet.edu.au.
Megan Hughes *Sexual Health Service Tasmania, Hobart, Australia.
Shannon ChristensenDisease Elimination, Burnet Institute, Melbourne, Australia.
Louisa WalshDisease Elimination, Burnet Institute, Melbourne, Australia.
Jacqueline A RichmondDisease Elimination, Burnet Institute, Melbourne, Australia.
Alisa PedranaDisease Elimination, Burnet Institute, Melbourne, Australia.
Anna L WilkinsonDisease Elimination, Burnet Institute, Melbourne, Australia.
Louise Owen *Sexual Health Service Tasmania, Hobart, Australia.
Joseph S Doyle *Disease Elimination, Burnet Institute, Melbourne, Australia.
EC Australia Partnership
The Australian Prevention Partnership Centre · AUBurnet Institute · AUInland Fisheries Service · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAustralia has experienced sustained reductions in hepatitis C testing and treatment and may miss its 2030 elimination targets. Addressing gaps in community-based hepatitis C prescribing in priority settings that did not have, or did not prioritise, hepatitis C testing and treatment care pathways is critical.

methodsThe Tasmanian Eliminate Hepatitis C Australia Outreach Project delivered a nurse-led outreach model of care servicing hepatitis C priority populations in the community through the Tasmanian Statewide Sexual Health Service, supported by the Eliminating Hepatitis C Australia partnership. Settings included alcohol and other drug services, needle and syringe programs and mental health services. The project provided clients with clinical care across the hepatitis C cascade of care, including testing, treatment, and post-treatment support and hepatitis C education for staff.

resultsBetween July 2020 and July 2022, a total of 43 sites were visited by one Clinical Nurse Consultant. There was a total of 695 interactions with clients across 219 days of service delivery by the Clinical Nurse Consultant. A total of 383 clients were tested for hepatitis C (antibody, RNA, or both). A total of 75 clients were diagnosed with hepatitis C RNA, of which 95% (71/75) commenced treatment, 83% (62/75) completed treatment and 52% (39/75) received a negative hepatitis C RNA test at least 12 weeks after treatment completion.

conclusionsProviding outreach hepatitis C services in community-based services was effective in engaging people living with and at-risk of hepatitis C, in education, testing, and care. Nurse-led, person-centred care was critical to the success of the project. Our evaluation underscores the importance of employing a partnership approach when delivering hepatitis C models of care in community settings, and incorporating workforce education and capacity-building activities when working with non-specialist healthcare professionals.

Indexed as

Hepatitis CSubstance Abuse, IntravenousAntiviral AgentsAustraliaHepacivirusHumansNurse's RoleRNAAntiviral AgentsRNAAustraliaDirect-acting antiviralsHepatitis CNurse-led model of carePeople who inject drugs

Identifiers

PMID37985979
PMCPMC10662700
OpenAlexW4388826065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.